跳至主要内容
临床试验/DRKS00021511
DRKS00021511尚未招募未知

A multicenter, investigator-blinded, randomized, controlled, parallel-group interventional exploratory phase IV trial to evaluate the effect of virtual reality enhanced patient education on illness perception, beliefs about medicines, adherence and disease activity in rheumatoid arthritis – the VIABLE-RA study - VIABLE-RA

Campus Kerckhoff der Justus Liebig Universität Giessen, Abt. für Rheumatologie, Immunologie, Osteologie und Physikalische Medizin0 个研究点目标入组 60 人开始时间: 2021年9月20日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 90 Years(—)
性别
All

入选标准

  • patients with rheumatoid arthritis

排除标准

  • neurological disorder
  • disorder/disease of ears, eyes, brain
  • traumata head / ears

研究者

发起方
Campus Kerckhoff der Justus Liebig Universität Giessen, Abt. für Rheumatologie, Immunologie, Osteologie und Physikalische Medizin

相似试验

进行中(未招募)
不适用
Efficacy and Safety of the paediatric formulation (dispersible tablet) of Coartem® in Children (weighing 5 kg to less than 35 kg ) with uncomplicated Plasmodium falciparum malaria
EUCTR2012-001333-14-Outside-EU/EEAovartis Pharma AG890
进行中(未招募)
不适用
A study to compare the polyp (tissue mass in the gut) detection rate after bowel cleansing using 2 different types of preparatioPatients with clinical symptoms or polyp history scheduled for either a diagnostic/surveillance colonoscopy or for a screening procedure in patients with a personal or familial risk of colon neoplasia.MedDRA version: 15.0Level: PTClassification code 10010007Term: ColonoscopySystem Organ Class: 10022891 - Investigations
EUCTR2011-002364-25-DEorgine Limited
进行中(未招募)
不适用
Study to compare the Metvix® efficacy in eliminating the actinic (solar) keratoses when activated by the natural daylight or by a red lampMild and/or moderate Actinic KeratosesMedDRA version: 16.0Level: HLTClassification code 10020648Term: HyperkeratosesSystem Organ Class: 100000004858
EUCTR2013-000973-54-DEGalderma R&D SNC120
进行中(未招募)
不适用
Study to compare the Metvix® efficacy in eliminating the actinic (solar) keratoses when activated by the natural daylight or by a red lampMild and/or moderate Actinic KeratosesMedDRA version: 14.1Level: HLTClassification code 10020648Term: HyperkeratosesSystem Organ Class: 100000004858
EUCTR2013-000973-54-SEGalderma R&D SNC120
进行中(未招募)
1 期
Study to compare the Metvix® efficacy in eliminating the actinic (solar) keratoses when activated by the natural daylight or by a red lampMild and/or moderate Actinic KeratosesMedDRA version: 16.0Level: HLTClassification code 10020648Term: HyperkeratosesSystem Organ Class: 100000004858
EUCTR2013-000973-54-ESGalderma R&D SNC131